Drug intelligence / Profile preview

HUBS + chlorhexidine gluconate

Development stage
Unknown
Lead developer
Garonit Pharmaceutical
Modality
Small Molecules
Administration
Topical, Oral, Mucosal
01

Overview

**HUBS + chlorhexidine gluconate** is a combination of two components: HUBS, which cannot be definitively identified as an established pharmaceutical agent or code name based on current sources, and **chlorhexidine gluconate**, a well-known antiseptic and disinfectant. Chlorhexidine gluconate is widely used for bacterial reduction in the mouth (as a mouthwash or oral rinse) and as a topical antiseptic in healthcare settings. Chlorhexidine gluconate acts by disrupting microbial cell membranes, leading to rapid bactericidal effects against Gram-positive and Gram-negative bacteria, as well as other microorganisms. Its common clinical uses include treatment of gingivitis, disinfection of skin or wounds, and preoperative site preparation. As a combination, if HUBS is an established antimicrobial, device, or excipient, this combination may serve as a local antimicrobial therapy, possibly in dental, wound, or catheter-related applications. However, no approved or registered pharmaceutical product, fixed-dose combination, or device is uniquely identified as "HUBS + chlorhexidine gluconate" in public drug or device registries.[1][2][3][4][5][7]

02

Targets

Lipid A

Beyond the preview

Go deeper on HUBS + chlorhexidine gluconate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HUBS + chlorhexidine gluconate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call